Healthy Balance SheetManageable leverage and a strong equity base provide durable financial flexibility. This capital structure supports funding for working capital and selective investment without excessive refinancing risk, offering a multi-month buffer against cyclical revenue dips and external shocks.

Positive Return On EquitySustained positive ROE indicates the business can generate shareholder returns from its existing capital. Even with variability, positive ROE over time implies competent capital allocation and an underlying profitable franchise able to reinvest earnings to support midterm growth.

Stable Operating MarginsConsistent gross and positive operating margins reflect durable operational efficiency and pricing or cost control advantages. Stable margins help absorb revenue shocks, sustain internal cash generation capacity, and support reinvestment or strategic initiatives over the next several months.

Bears Say

Inconsistent Cash GenerationNegative free cash flow growth and inconsistent operating cash conversion constrain the firm's ability to fund growth internally. Persistent high capex versus cash generation can force external financing, limit strategic flexibility, and raise liquidity risk over a multi-month horizon.

Recent Revenue DeclineA latest-year revenue decline combined with profit volatility signals structural demand, pricing, or competitive pressures. Without a clear, sustained recovery in top-line trends, this undermines long-term margin stability and cash flow predictability for several months to quarters ahead.

Limited Operational ScaleA very small workforce suggests constrained manufacturing, R&D, and commercial capacity relative to peers. Limited scale increases reliance on key personnel, reduces diversification, and can slow expansion or contract wins, impeding sustainable growth and resilience over the medium term.

Biofil Chemicals & Pharmaceuticals Ltd. News

Biofil Chemicals Announces Virtual AGM and E-Voting

An update from Biofil Chemicals & Pharmaceuticals Ltd. ( ($IN:BIOFILCHEM) ) is now available. Biofil Chemicals & Pharmaceuticals...

6M ago

Biofil Chemicals Appoints New Company Secretary

The latest announcement is out from Biofil Chemicals & Pharmaceuticals Ltd. ( ($IN:BIOFILCHEM) ). Biofil Chemicals & Pharmaceuticals...

10M ago

Biofil Chemicals & Pharmaceuticals Ltd. Appoints New Company Secretary

Biofil Chemicals & Pharmaceuticals Ltd. ( ($IN:BIOFILCHEM) ) just unveiled an update. Biofil Chemicals & Pharmaceuticals Ltd. has...

10M ago

Biofil Chemicals Appoints New Company Secretary to Enhance Compliance

Biofil Chemicals & Pharmaceuticals Ltd. ( ($IN:BIOFILCHEM) ) has provided an update. Biofil Chemicals & Pharmaceuticals Ltd. has...

10M ago

BIOFILCHEM FAQ

What was Biofil Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?

Biofil Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹28.79 and its highest was ₹56.36 in the past 12 months.

What is Biofil Chemicals & Pharmaceuticals Ltd.’s market cap?

Biofil Chemicals & Pharmaceuticals Ltd.’s market cap is ₹560.14M.

When is Biofil Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?

Biofil Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 101 days.

How were Biofil Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?

Biofil Chemicals & Pharmaceuticals Ltd. released its earnings results on Feb 13, 2026. The company reported ₹0.049 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.049.

Is Biofil Chemicals & Pharmaceuticals Ltd. overvalued?

According to Wall Street analysts Biofil Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Biofil Chemicals & Pharmaceuticals Ltd. pay dividends?

Biofil Chemicals & Pharmaceuticals Ltd. does not currently pay dividends.

What is Biofil Chemicals & Pharmaceuticals Ltd.’s EPS estimate?

Biofil Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Biofil Chemicals & Pharmaceuticals Ltd. have?

Biofil Chemicals & Pharmaceuticals Ltd. has 16,273,800 shares outstanding.

What happened to Biofil Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?

Biofil Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹0.049 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.921%.

Which hedge fund is a major shareholder of Biofil Chemicals & Pharmaceuticals Ltd.?

Currently, no hedge funds are holding shares in IN:BIOFILCHEM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Biofil Chemicals & Pharmaceuticals Ltd.

Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. The company was incorporated in 1985 and is based in Indore, India.